Drug Profile
Research programme: pain therapeutics - Solace Pharmaceuticals
Alternative Names: GCH1 inhibitors - SolaceLatest Information Update: 29 Jun 2015
Price :
$50
*
At a glance
- Originator Solace Pharmaceuticals
- Class
- Mechanism of Action GTP cyclohydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain